The role of lipopolysaccharide as a marker of immune activation in HIV-1 infected patients: a systematic literature review

[1]  M. Ticchioni,et al.  The role of lipopolysaccharide as a marker of immune activation in HIV-1 infected patients: a systematic literature review , 2012, Virology Journal.

[2]  A. d’Arminio Monforte,et al.  Microbial translocation predicts disease progression of HIV-infected antiretroviral-naive patients with high CD4+ cell count , 2011, AIDS.

[3]  G. d’Ettorre,et al.  HIV persistence in the gut mucosa of HIV-infected subjects undergoing antiretroviral therapy correlates with immune activation and increased levels of LPS. , 2011, Current HIV research.

[4]  T. Rossouw,et al.  Microbial translocation: a marker of advanced HIV-1 infection and a predictor of treatment failure? , 2011, The Journal of infectious diseases.

[5]  J. Benito,et al.  Elite controllers display higher activation on central memory CD8 T cells than HIV patients successfully on HAART. , 2011, AIDS research and human retroviruses.

[6]  H. Hartung,et al.  Microbial Translocation Correlates with the Severity of Both HIV-1 and HIV-2 Infections , 2010 .

[7]  S. Pittaluga,et al.  Damaged Intestinal Epithelial Integrity Linked to Microbial Translocation in Pathogenic Simian Immunodeficiency Virus Infections , 2010, PLoS pathogens.

[8]  M. Wallet,et al.  Microbial translocation induces persistent macrophage activation unrelated to HIV-1 levels or T-cell activation following therapy , 2010, AIDS.

[9]  F. Månsson,et al.  Microbial translocation correlates with the severity of both HIV-1 and HIV-2 infections. , 2010, The Journal of infectious diseases.

[10]  L. Palmisano,et al.  Microbial translocation is associated with residual viral replication in HAART-treated HIV+ subjects with <50copies/ml HIV-1 RNA. , 2009, Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology.

[11]  J. Margolick,et al.  Microbial translocation, the innate cytokine response, and HIV-1 disease progression in Africa , 2009, Proceedings of the National Academy of Sciences.

[12]  M. Lederman,et al.  Plasma levels of bacterial DNA correlate with immune activation and the magnitude of immune restoration in persons with antiretroviral-treated HIV infection. , 2009, The Journal of infectious diseases.

[13]  B. Shiramizu,et al.  Characteristics of Activated Monocyte Phenotype Support R5-Tropic Human Immunodeficiency Virus. , 2009, Immunology and immunogenetics insights.

[14]  P. Janmey,et al.  Delayed loss of control of plasma lipopolysaccharide levels after therapy interruption in chronically HIV-1-infected patients , 2009, AIDS (London).

[15]  C. Loddenkemper,et al.  Impairment of the intestinal barrier is evident in untreated but absent in suppressively treated HIV-infected patients , 2008, Gut.

[16]  S. Ray,et al.  Human immunodeficiency virus-related microbial translocation and progression of hepatitis C. , 2008, Gastroenterology.

[17]  Steven Wolinsky,et al.  Microbial Translocation Is Associated with Increased Monocyte Activation and Dementia in AIDS Patients , 2008, PloS one.

[18]  Jeffrey N. Martin,et al.  Relationship between T cell activation and CD4+ T cell count in HIV-seropositive individuals with undetectable plasma HIV RNA levels in the absence of therapy. , 2008, The Journal of infectious diseases.

[19]  J. Brenchley,et al.  Microbial translocation is a cause of systemic immune activation in chronic HIV infection , 2006, Retrovirology.

[20]  A. Wurcel,et al.  CD16+ Monocyte-Derived Macrophages Activate Resting T Cells for HIV Infection by Producing CCR3 and CCR4 Ligands1 , 2006, The Journal of Immunology.

[21]  D. Dormont,et al.  Macrophage activation switching: an asset for the resolution of inflammation , 2005, Clinical and experimental immunology.

[22]  H. Volk,et al.  Impaired antigen presentation by human monocytes during endotoxin tolerance. , 2000, Blood.

[23]  L. Wang,et al.  Virology Journal , 1966, Nature.